The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2016

Filed:

Dec. 05, 2014
Applicant:

Theranos, Inc., Palo Alto, CA (US);

Inventors:

Ian Gibbons;

Anthony J. Nugent, Palo Alto, CA (US);

Anthony Delacruz, Palo Alto, CA (US);

Daniel L. Young, Palo Alto, CA (US);

Elizabeth A. Holmes, Palo Alto, CA (US);

Andrew Drake, Palo Alto, CA (US);

Timothy Michael Kemp, Palo Alto, CA (US);

Sunny Balwani, Palo Alto, CA (US);

Chinmay Pangarkar, Palo Alto, CA (US);

Assignee:

Theranos, Inc., Palo Alto, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 21/00 (2006.01); G01N 33/543 (2006.01); G01N 21/03 (2006.01); G01N 21/51 (2006.01); C12Q 1/42 (2006.01); C12Q 1/48 (2006.01); C12Q 1/68 (2006.01); G01N 21/59 (2006.01); G01N 33/569 (2006.01); G01N 33/573 (2006.01); G01N 33/74 (2006.01); G01N 33/80 (2006.01); G06T 3/40 (2006.01); G06T 7/00 (2006.01); H04N 5/232 (2006.01); C12Q 1/52 (2006.01); G01N 1/40 (2006.01); G01N 33/53 (2006.01); G01N 33/82 (2006.01); G01N 33/92 (2006.01); G01N 35/10 (2006.01); B01L 3/02 (2006.01); G06F 19/00 (2011.01); G01N 35/00 (2006.01);
U.S. Cl.
CPC ...
G01N 21/00 (2013.01); C12Q 1/42 (2013.01); C12Q 1/48 (2013.01); C12Q 1/52 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/689 (2013.01); C12Q 1/6809 (2013.01); G01N 1/4077 (2013.01); G01N 21/0303 (2013.01); G01N 21/51 (2013.01); G01N 21/59 (2013.01); G01N 33/5308 (2013.01); G01N 33/54326 (2013.01); G01N 33/54393 (2013.01); G01N 33/56972 (2013.01); G01N 33/56983 (2013.01); G01N 33/573 (2013.01); G01N 33/74 (2013.01); G01N 33/743 (2013.01); G01N 33/80 (2013.01); G01N 33/82 (2013.01); G01N 33/92 (2013.01); G01N 35/10 (2013.01); G06T 3/4084 (2013.01); G06T 7/0002 (2013.01); G06T 7/0012 (2013.01); H04N 5/23222 (2013.01); B01L 3/0275 (2013.01); B01L 2300/168 (2013.01); C12Q 2600/158 (2013.01); G01N 2001/4083 (2013.01); G01N 2035/00495 (2013.01); G01N 2333/575 (2013.01); G01N 2333/62 (2013.01); G01N 2333/91188 (2013.01); G01N 2333/96463 (2013.01); G06F 19/703 (2013.01); G06T 2207/30004 (2013.01); G06T 2207/30168 (2013.01);
Abstract

The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.


Find Patent Forward Citations

Loading…